Clinical handbook of psychotropic drugs
New in this edition: Third-generation antipsychotics with major additions and changes Pharmacogenomics fully revised ECT thoroughly revised and updated BLT / rTMS with extended references Extrapyramidal side effects chart extended Antidepressants vilazodone and vortioxetine with extended coverage Ne...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Hogrefe
2017
|
| Ausgabe: | 22 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | New in this edition: Third-generation antipsychotics with major additions and changes Pharmacogenomics fully revised ECT thoroughly revised and updated BLT / rTMS with extended references Extrapyramidal side effects chart extended Antidepressants vilazodone and vortioxetine with extended coverage New chart of agents under investigation for treatment of substance use disorders Approved and off-label indications updated New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra) New formulations and tradenames include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XR. |
|---|---|
| Beschreibung: | Includes index OCLC-licensed vendor bibliographic record |
| Beschreibung: | 1 online resource (431 pages .) |
| ISBN: | 1616764961 9781616764968 |